Kevin Mc Carl
About Kevin Mc Carl
Kevin Mc Carl serves as the Vice President of Global Marketing and Global Product Team Lead at Prothena Corporation plc, where he has worked since 2020. He has extensive experience in the biotechnology industry, having held various leadership roles at Amgen and other organizations.
Current Role at Prothena Corporation
Kevin Mc Carl serves as the Vice President of Global Marketing and Global Product Team Lead at Prothena Corporation plc. He has held this position since 2020, overseeing the company's marketing strategies and leading cross-functional teams. He is responsible for the commercial assessments of out and in-licensing opportunities and focuses on pipeline assets in hematology and neurodegenerative diseases. Mc Carl reports directly to the Chief Operating Officer.
Previous Experience at Amgen
Prior to his current role, Mc Carl worked at Amgen in various capacities. He served as the Director of US Value & Access Commercial Insights from 2019 to 2020 and as the Director of US Marketing Operations and Omnichannel Customer Engagement from 2017 to 2019. He also held the position of Director, Global Marketing Lead for Vectibix and Director, Global Commercial Insights Lead for Oncology from 2013 to 2016. His tenure at Amgen included a role as Senior Manager of Commercial Insights in 2011.
Career Background at ZS Associates and Intel
Before joining Amgen, Mc Carl worked as an Engagement Manager at ZS Associates from 2005 to 2011, where he contributed to various client engagements in the healthcare sector. He also had a brief internship as a Strategic Planning Intern at Intel in 2004, which provided him with foundational experience in strategic planning.
Education and Academic Achievements
Mc Carl earned his MBA in Marketing and Strategy from Duke University's Fuqua School of Business, completing his studies from 2003 to 2005. He also holds a Bachelor of Science in Mechanical Engineering from Texas A&M University, where he studied from 1994 to 1998. His educational background supports his expertise in marketing and product strategy.
Leadership in Product Development
In his role at Prothena, Mc Carl leads the global product team for birtamimab, the company's lead asset. He presented and received approval for a comprehensive four-year go-to-market plan for birtamimab from the board of directors, showcasing his strategic planning capabilities and leadership in product development.